Ureidophenyl substituted triazine derivatives and their therapeutical applications
Details for Australian Patent Application No. 2010258825 (hide)
International Classifications
Event Publications
12 January 2012 PCT application entered the National Phase
PCT publication WO2010/144522 Priority application(s): WO2010/144522
1 March 2012 Assignment before Grant
Abraxis BioScience, LLC The application has been assigned to California Capital Equity, LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010258838-Methods and compositions for the induction of hypothermia
2010258821-Genotype specific methods for treating human subjects using 4methylpyrazole
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser